Dr Morten Blinkenberg
MD, PhD, consultant neurologist, Department of Neurology, Rigshospitalet, Copenhagen University Hospital, Denmark.
Associated researcher at Neurobiological Research Unit, Rigshospitalet, Copenhagen University Hospital, Denmark. As areas of special research interest he has focused on neuroimaging, primarily positron emission tomography (PET) and Multiple Sclerosis (MS), but he has also published articles regarding basic scientific issues and PET activation. Dr Blinkenberg is currently continuing his scientific work on MS and PET/MRI as well as PET studies of malignant brain tumors.
Contributions to CNSforum by Dr Morten Blinkenberg:
24.11.2006
Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II-defined cohort of patients with progressive multiple sclerosis: results of a 24-month double-blind placebo-controlled clinical trial and 5 years of follow-up treatment
26.10.2006
Oral fingolimod (FTY720) for relapsing multiple sclerosis
27.09.2006
The risk of relapses in multiple sclerosis during systemic infections
24.08.2006
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
25.07.2006
Significance of T2 lesions in multiple sclerosis: A 13-year longitudinal study
23.06.2006
Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event
23.05.2006
Mitoxantrone versus cyclophosphamide in secondary-progressive multiple sclerosis : A comparative study
28.04.2006
IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event
22.03.2006
Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis
20.02.2006
Natural history of multiple sclerosis: a unifying concept
17.01.2006
Efficacy of azathioprine on multiple sclerosis new brain lesions evaluated using magnetic resonance imaging
22.11.2005
Cortical demyelination and diffuse white matter injury in multiple sclerosis
23.10.2005
Appearance and disappearance of neutralizing antibodies during interferon-beta therapy
27.09.2005
Familial Risk of Multiple Sclerosis: A Nationwide Cohort Study
22.08.2005
Brain atrophy and lesion load in a large population of patients with multiple sclerosis
26.07.2005
The combination of cyclophosphamide plus interferon beta as rescue therapy could be used to treat relapsing-remitting multiple sclerosis patients Twenty-four months follow-up
16.06.2005
Donepezil improved memory in multiple sclerosis in a randomized clinical trial
20.05.2005
Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study
21.04.2005
Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study
22.03.2005
Resistance training improves strength and functional capacity in persons with multiple sclerosis
19.02.2005
Is optic neuritis more benign than other first attacks in multiple sclerosis?
24.01.2005
The unique impact of changes in normal appearing brain tissue on cognitive dysfunction in secondary progressive multiple sclerosis patients
22.11.2004
Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial
22.10.2004
Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis
22.09.2004
Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial
23.08.2004
Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS
28.07.2004
The relationship between diffuse axonal damage and fatigue in multiple sclerosis
28.06.2004
Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse.
24.05.2004
Trends in survival and cause of death in Danish patients with multiple sclerosis
19.04.2004
Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion.
23.03.2004
Clinical and MRI outcome after autologous hematopoietic stem cell transplantation in MS
23.02.2004
Vitamin D intake and incidence of multiple sclerosis
28.01.2004
Atrophy is detectable within a 3-month period in untreated patients with active relapsing remitting multiple sclerosis
30.12.2003
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
21.11.2003
Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis
23.10.2003
A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment.
25.09.2003
Pain in patients with multiple sclerosis: a population-based study
22.08.2003
Health-related quality of life and depression in an Italian sample of multiple sclerosis patients.
28.07.2003
Gelatinase B/matrix metalloproteinase-9 cleaves interferon-beta and is a target for immunotherapy
19.06.2003
High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection.
26.05.2003
Cognitive impairment in probable multiple sclerosis
30.04.2003
Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process
21.03.2003
Persistent neutralizing antibodies abolish the interferon ß bioavailability in MS patients
24.02.2003
Brain Diffusion after Single Seizures
24.02.2003
Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial
28.01.2003
Cerebral Activation during Vagus Nerve Stimulation: A Functional MR Study
28.01.2003
Functional brain reorganization for hand movement in patients with multiple sclerosis: defining distinct effects of injury and disability
16.12.2002
Eight-year follow-up study of brain atrophy in patients with MS
16.12.2002
Long term outcome of temporal lobe epilepsy surgery: analyses of 140 consecutive patients
22.11.2002
Metabolic and Electrophysiological Alterations in Subtypes of Temporal Lobe Epilepsy: A Combined Proton Magnetic Resonance Spectroscopic Imaging and Depth Electrodes Study
22.11.2002
Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing–remitting multiple sclerosis
21.10.2002
Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis?
21.10.2002
Interictal EEG Abnormalities in Patients with Psychogenic Nonepileptic Seizures
25.09.2002
Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS
25.09.2002
Responses to single pulse electrical stimulation identify epileptogenesis in the human brain in vivo
19.08.2002
Magnetization transfer imaging in normal aging, mild cognitive impairment, and Alzheimer's disease
19.08.2002
Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis